Teladoc Health, Inc. (NYSE:TDOC) Receives $11.97 Consensus Target Price from Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned an average recommendation of “Hold” from the twenty-one research firms that are presently covering the firm, Marketbeat.com reports. Fourteen research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $12.08.

Several equities analysts have commented on the stock. Truist Financial dropped their price target on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Royal Bank of Canada upped their target price on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a report on Wednesday, October 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st.

Teladoc Health Stock Down 1.3 %

Shares of NYSE TDOC opened at $8.93 on Wednesday. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.54. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.54 billion, a PE ratio of -1.55 and a beta of 0.90. The company has a 50-day moving average of $8.96 and a 200 day moving average of $9.31.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts predict that Teladoc Health will post -1.17 EPS for the current fiscal year.

Insider Activity

In other news, Director Thomas Mckinley bought 4,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was acquired at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the acquisition, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Mala Murthy sold 8,750 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This trade represents a 9.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,051 shares of company stock valued at $143,565 in the last ninety days. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Institutional investors have recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Teladoc Health by 2.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock worth $641,000 after purchasing an additional 1,352 shares in the last quarter. Covestor Ltd lifted its position in Teladoc Health by 58.1% during the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after acquiring an additional 1,403 shares in the last quarter. Signaturefd LLC lifted its position in Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares in the last quarter. Swiss National Bank boosted its holdings in Teladoc Health by 0.6% in the 1st quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock worth $4,936,000 after acquiring an additional 1,800 shares during the period. Finally, Blue Trust Inc. grew its position in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.